Aeterna Zentaris (AEZS) - Net earnings per share (EPS TTM)

Symbol and logo of brand Aeterna Zentaris Inc. (AEZS)

High-margin licensing royalties stabilize the cash flow of Aeterna Zentaris (AEZS), while R&D activity is currently restrained and strictly regulated. The current EPS TTM reflects equity income dynamics, where the value -2.31 represents the current metric. Meanwhile, the production of orphan drugs relies on automated conveyor systems that minimize personnel involvement in packaging.

AEZS (zentaris.com) Earnings per share for the last 12 months history from 07/04/2022 to 08/17/2024

Comprehensive metric breakdowns and analytics for Zentaris (AEZS)

- share price and expert price forecast:
General company analysis:Aeterna Zentaris Inc. (AEZS)
Mass-produced product of Aeterna Zentaris Inc

This indicator reflects operational efficiency by excluding the impact of one-time accounting adjustments on the final financial result. The metric measures the portion of net profit attributable to a single common share per year. For the specialty pharmaceutical company Aeterna Zentaris (AEZS), such profit stability confirms the defensive qualities of the business. Regulatory risks carry more weight here than market cycles. The 12-month net profit per share trend for Aeterna Zentaris (AEZS) helps identify changes in profitability in a timely manner.

Competitors of Aeterna Zentaris (AEZS)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp. (UTHR)|BMRN (BioMarin) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio)|Earnings per share for the last twelve months bgm.ltd (BGM)|COGT (Cogent Biosciences Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months Xeris Biopharma Holdings XERS|KROS (Keros Pharma) - Earnings per one share for the last 12 months|Arcturus Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ETON (Eton Pharmaceuticals)|KMDA: Net earnings per share (EPS TTM)|Fulcrum Therapeutics Inc (FULC) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months abeonatherapeutics.com|MREO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PLX|Net earnings per share for the last 12 months Pliant Therapeutics, Inc. PLRX|Net earnings per share (EPS TTM) APLT (Applied Therapeutics Inc.)|Net earnings per share (EPS TTM) Rein Therapeutics Inc. RNTX|gelteq.com - Net earnings per share (EPS TTM)|AYTU - Net earnings per share (EPS TTM)|CMMB: Net earnings per share (EPS TTM)|SRx Health Solutions Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Polyrizon Ltd|Net earnings per share for the last 12 months Cyclo Therapeutics Inc. (CYTH)|Net earnings per share for the last 12 months INZY (inozyme.com)|RPHM - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CSCI (cosciensbio.com)